Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration

Published:2022-01-01 Issue:1 Volume:140 Page:20
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Khanani Arshad M.¹²,Zarbin Marco A.³,Barakat Mark R.⁴,Albini Thomas A.⁵,Kaiser Peter K.⁶,B Guruprasad⁷,Agashivala Neetu⁷,Yu Justin S.⁷,Wykoff Charles C.⁸⁹,MacCumber Mathew W.¹⁰¹¹

Affiliation:

1. Sierra Eye Associates, Reno, Nevada

2. Reno School of Medicine, University of Nevada, Reno

3. Institute of Ophthalmology and Visual Science, Rutgers–New Jersey Medical School, Rutgers University, Newark, New Jersey

4. Retinal Consultants of Arizona, Phoenix

5. Bascom Palmer Eye Institute, Miami, Florida

6. Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio

7. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey

8. Retina Consultants of Texas, Houston

9. Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas

10. Department of Ophthalmology at Rush University Medical Center, Chicago, Illinois

11. Illinois Retina Associates, SC, Chicago

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2786559/jamaophthalmology_khanani_2021_oi_210067_1641846882.96138.pdf

Reference27 articles.

1. Age-Related Macular Degeneration Preferred Practice Pattern®.;Flaxel;Ophthalmology,2020

2. Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration.;Yannuzzi;Clin Ophthalmol,2019

3. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration.;Dugel;Ophthalmology,2020

4. Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration.;Haug;Am J Ophthalmol Case Rep,2020

5. Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations.;Jain;Am J Ophthalmol Case Rep,2020

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and Vasculitis Related to Brolucizumab;Journal of Clinical Medicine;2024-09-02

2. Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1;Journal of VitreoRetinal Diseases;2024-08-22

3. Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group;Indian Journal of Ophthalmology;2024-07-29

4. Treatment of neovascular age-related macular degeneration with anti-vascular endothelial growth factor drugs: progress from mechanisms to clinical applications;Frontiers in Medicine;2024-07-19

5. Leveraging Real-World Evidence to Enhance Clinical Trials;Ophthalmology;2024-07